Available as a global test only. Markers tested by flow cytometry include CD19, CD20, CD27, CD38, CD45, CD56, CD117, CD138, cKappa, and cLambda.
Available as an add-on with an Intelligent Flow Profile. Markers tested by flow cytometry include CD5, CD11c, CD19, CD20, CD22, CD25, CD45, CD103, and FMC7.
Available as a global test only. Markers tested by flow cytometry include CD3, CD5, CD19, CD20, CD22, CD43, CD79b, CD81.
Available as an add-on with an Intelligent Flow Profile. Markers tested by flow cytometry include cKappa, cLambda, CD5, CD19, CD10, CD11c, CD19, and CD20.
Available as a global test only. Markers tested by flow cytometry include CD123, CD45, CD19, CD34, CD38, CD10, CD22, CD58, CD66C, CD9, CD13, CD33, and CD20.
Available as an add-on in conjunction with, or after, a Diagnostic/Prognostic Profile result has been reported by Genoptix or client. Markers include cCD3, cCD22, CD33, CD34, CD45, CD79a, cMPO and nTdT.
Includes COMPASS® consultation report, clinical pathology evaluation, blood morphology (up to 10 cytochemical stains), flow cytometry (up to 40 antibodies), cytogenetics and/or fluorescent in situ hybridization (FISH) (up to 14 probes), and molecular tests as medically necessary.
CONTACT US
Genoptix, a NeoGenomics Company
2131 Faraday Ave
Carlsbad, CA 92008
Phone: +1.760.268.6200
Fax: +1.760.268.6201
Client Services
Phone: +1.800.755.1605
Fax: +1.888.755.1604
Email: clientservices@genoptix.com
Medical Director: Derek Lyle, MD
Recent News
NeoGenomics Completes Acquisition of Genoptix, Inc.December 10, 2018 - 9:00 am
NeoGenomics Signs Definitive Agreement to Acquire GenoptixOctober 23, 2018 - 9:00 am
Genoptix Launches FDA-Authorized BCR-ABL MRDx® TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna® (nilotinib)September 4, 2018 - 8:30 am
HOURS OF OPERATION
Our lab is open six days a week:
5:00am to 6:00pm PT Mon-Fri
7:00am to 3:30pm PT Saturday
For after-hours assistance, your call
will be connected with an on-duty
Client Services Representative.